CNSP
Price:
$6.51
Market Cap:
$3.74M
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas...[Read more]
Industry
Biotechnology
IPO Date
2019-11-08
Stock Exchange
NASDAQ
Ticker
CNSP
According to CNS Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6092778.00. This represents a change of -125.27% compared to the average of 24.11M of the last 4 quarters.
The mean historical Enterprise Value of CNS Pharmaceuticals, Inc. over the last ten years is 1.68T. The current -6092778.00 Enterprise Value has changed -100.04% with respect to the historical average. Over the past ten years (40 quarters), CNSP's Enterprise Value was at its highest in in the March 2019 quarter at 3.74T. The Enterprise Value was at its lowest in in the June 2025 quarter at -11702760.30.
Average
1.68T
Median
1.18T
Minimum
16.78M
Maximum
3.74T
Discovering the peaks and valleys of CNS Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 45.73%
Maximum Annual Enterprise Value = 3.74T
Minimum Annual Increase = -99.99%
Minimum Annual Enterprise Value = 16.78M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 16.78M | -99.99% |
| 2023 | 237.17B | 45.73% |
| 2022 | 162.75B | -81.75% |
| 2021 | 891.97B | -39.02% |
| 2020 | 1.46T | -54.80% |
| 2019 | 3.24T | -13.57% |
| 2018 | 3.74T | 0.00% |
The current Enterprise Value of CNS Pharmaceuticals, Inc. (CNSP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
133.31B
5-year avg
550.90B
10-year avg
1.68T
CNS Pharmaceuticals, Inc.’s Enterprise Value is less than Windtree Therapeutics, Inc. (5.19M), greater than Pasithea Therapeutics Corp. (-4114320103.00), less than NLS Pharmaceutics AG (-1903124.00), less than Soligenix, Inc. (11.75M), less than Oragenics, Inc. (4.58M), less than 60 Degrees Pharmaceuticals, Inc. (-953780.00), less than Clearmind Medicine Inc. (-3714308.00), less than Ensysce Biosciences, Inc. (2.58M), less than GRI Bio, Inc. (356.75K), less than Silo Pharma, Inc. (-324685.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.19M | $2.02M | |
| -4114320103.00 | $8.63M | |
| -1903124.00 | $1.17M | |
| 11.75M | $16.43M | |
| 4.58M | $3.55M | |
| -953780.00 | $3.16M | |
| -3714308.00 | $722.23K | |
| 2.58M | $3.86M | |
| 356.75K | $5.38M | |
| -324685.00 | $3.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNS Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CNS Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CNS Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for CNS Pharmaceuticals, Inc. (CNSP)?
What is the 3-year average Enterprise Value for CNS Pharmaceuticals, Inc. (CNSP)?
What is the 5-year average Enterprise Value for CNS Pharmaceuticals, Inc. (CNSP)?
How does the current Enterprise Value for CNS Pharmaceuticals, Inc. (CNSP) compare to its historical average?